135 related articles for article (PubMed ID: 9330414)
41. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD; Moore A; Mersmann S; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
[TBL] [Abstract][Full Text] [Related]
43. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
44. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate.
Wong JY; Zacharin MR; Hocking N; Robinson PJ
J Paediatr Child Health; 2002 Feb; 38(1):59-62. PubMed ID: 11869402
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
46. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
47. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate.
Eid N; Morton R; Olds B; Clark P; Sheikh S; Looney S
Pediatrics; 2002 Feb; 109(2):217-21. PubMed ID: 11826198
[TBL] [Abstract][Full Text] [Related]
48. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
49. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[TBL] [Abstract][Full Text] [Related]
50. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
51. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
52. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.
Vaessen-Verberne AA; van den Berg NJ; van Nierop JC; Brackel HJ; Gerrits GP; Hop WC; Duiverman EJ;
Am J Respir Crit Care Med; 2010 Nov; 182(10):1221-7. PubMed ID: 20622031
[TBL] [Abstract][Full Text] [Related]
53. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
[TBL] [Abstract][Full Text] [Related]
55. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
56. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
Visser MJ; Postma DS; Arends LR; de Vries TW; Duiverman EJ; Brand PL
Am J Respir Crit Care Med; 2001 Dec; 164(11):2073-7. PubMed ID: 11739137
[TBL] [Abstract][Full Text] [Related]
57. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
[TBL] [Abstract][Full Text] [Related]
58. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[TBL] [Abstract][Full Text] [Related]
59. Urinary fluticasone propionate-17beta-carboxylic acid to assess asthma therapy adherence.
Hagan JB; Netzel BC; Matthews MR; Korpi-Steiner NL; Singh RJ
Allergy Asthma Proc; 2012; 33(4):e35-9. PubMed ID: 22856629
[TBL] [Abstract][Full Text] [Related]
60. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]